10-K – 2025-10-03 – mu-20250828.htm

We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

As a result of reorganizing our segments in the fourth quarter of 2025, we reallocated goodwill among our reporting units on a relative fair value basis. We performed a quantitative goodwill impairment assessment for each of our reporting units immediately before and after our business unit reorganization. We concluded based on both our pre- and post-reorganization impairment assessments that goodwill was not impaired. As of August 28, 2025, CMBU, CDBU, MCBU, and AEBU had goodwill of $ 654  million, $ 109  million, $ 284  million, and $ 103  million, respectively.

96

Table of Contents

We performed a qualitative assessment for goodwill impairment in 2024 and did not identify any impairment indicators for our reporting units. Due to global and macroeconomic challenges, as well as lower expected demand resulting from customer actions to reduce elevated inventory levels, in 2023, we performed a quantitative assessment for goodwill impairment for each of our reporting units. We evaluated the fair value of our reporting units based on an income approach, using a discounted cash flow methodology. We recognized a $ 101  million charge in 2023, included in other operating income (loss) to impair all of the goodwill assigned to our former Storage Business Unit based on our best estimates of projected future cash flows at that time.

Note 28. Certain Concentrations

Our business units are based on market segments. See Note 27. Segment and Other Information for disclosure of disaggregated revenue by market segment. Revenue from one customer was 17 % (primarily included in the CMBU segment) of total revenue for 2025. Revenue from one customer was 10 % (primarily included in the MCBU, AEBU, and CMBU segments) of total revenue for 2024. No customer accounted for 10% or more of total revenue in 2023.

We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier.

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-income securities, trade receivables, share repurchase, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitor credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our derivative hedging programs as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements.

97 | 2025 10-K

Table of Contents

Note 29. Geographic Information

Revenue based on the geographic location of our customers’ headquarters was as follows:
For the year ended 2025 2024 2023

U.S.
$ 24,113   $ 13,168   $ 7,805  
Taiwan 5,672   4,708   2,697  
Mainland China (excluding Hong Kong) 2,639   3,045   2,181  
Other Asia Pacific 1,913   1,330   752  
Hong Kong 1,138   1,071   340  
Japan 895   840   987  
Europe
625   818   682  
Other 383   131   96  
$ 37,378   $ 25,111   $ 15,540  

Long-lived assets by geographic area consisted of property, plant, and equipment and operating lease right-of-use assets and were as follows:
As of August 28,
2025 August 29,
2024

Taiwan $ 18,965   $ 14,156  
Singapore 10,669   10,588  
U.S.
8,445   6,508  
Japan 7,038   7,085  
Malaysia 1,124   1,153  
China 544   486  
India
449   338  
Other 92   80  
$ 47,326   $ 40,394  

98

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Micron Technology, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Micron Technology, Inc. and its subsidiaries (the “Company”) as of August 28, 2025 and August 29, 2024, and the related consolidated statements of operations, of comprehensive income (loss), of changes in equity and of cash flows for each of the three years in the period ended August 28, 2025, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended August 28, 2025 appearing under Item 15 (collectively referred to as the “consolidated financial statements”). We also have audited the Company’s internal control over financial reporting as of August 28, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of August 28, 2025 and August 29, 2024 , and the results of its operations and its cash flows for each of the three years in the period ended August 28, 2025 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of August 28, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

99 | 2025 10-K

Table of Contents

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Accounting for the U.S. CHIPS Act Funding Agreements

As described in Notes 1 and 20 to the consolidated financial statements, the Company has entered into direct funding agreements with the U.S. Department of Commerce for up to $6.4 billion in direct funding pursuant to the U.S. CHIPS Act for the Company’s U.S. manufacturing expansion and modernization projects in Idaho, New York, and Virginia. Funding will be based on the achievement of construction, tool installation, and wafer production milestones. The agreements contain representations, warranties, and covenants that relate to compliance with requirements for awards provided for in the U.S. CHIPS Act. In addition, the agreements include certain events of default and related rights and remedies, including clawbacks related to the failure to complete a project by an agreed upon completion date, violation of U.S. CHIPS Act restrictions on certain activities involving foreign countries and entities of concern, and impermissible use or disposition of a project. Government incentives are recognized in the financial statements based on the underlying principal criteria for earning the incentives when there is reasonable assurance that the conditions of the government incentives are met and the incentive will be received. Incentives related to the acquisition or construction of property, plant and equipment are recognized as a reduction in the carrying amounts of the related assets and as a reduction of subsequent depreciation expense over the useful lives of the assets. For each project, the Company estimates the total expected project costs and recognizes a proportionate benefit as qualified project costs are incurred. As the estimated total expected qualified project cost changes, the Company adjusts the estimate of the recognized proportionate benefit.

The principal considerations for our determination that performing procedures relating to accounting for the U.S. CHIPS Act funding agreements is a critical audit matter are (i) the significant judgment by management in assessing the accounting for the funding agreements, including the recognition of the proportionate benefit and the impacts of potential outcomes associated with compliance with covenants related to events of default and (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating audit evidence related to management’s assessment of the accounting for the funding agreements, including the assessment of the proportionate benefit and the compliance with covenants.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s assessment of the accounting for the U.S. CHIPS Act funding agreements, including controls over the recognition of the proportionate benefit and compliance with covenants related to events of default and the related disclosures. These procedures also included, among others (i) evaluating the completeness and accuracy of management’s identification of key terms and conditions by obtaining and inspecting
100

Table of Contents

the U.S. CHIPS Act funding agreements; (ii) evaluating whether the principal criteria, including milestone attainment and capital expenditures, for recognizing government incentives are probable, that the terms of the incentives are met, and that the incentives will be received; (iii) evaluating the reasonableness of management’s estimate of the total expected project costs and recognition of a proportionate benefit; (iv) tracing cash payments received from the U.S. Department of Commerce to supporting documentation, such as bank statements; and (v) evaluating the sufficiency of the Company’s disclosures related to the U.S. CHIPS Act funding agreements.

/s/ PricewaterhouseCoopers LLP

San Jose, California
October 3, 2025

We have served as the Company’s auditor since 1984.
101 | 2025 10-K

Table of Contents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

An evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that those disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including the principal executive officer and principal financial officer, to allow timely decisions regarding disclosure.

During the fourth quarter of 2025, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that our internal control over financial reporting was effective as of August 28, 2025. The effectiveness of our internal control over financial reporting as of August 28, 2025 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included in Part II, Item 8, of this Annual Report on Form 10-K.

102

Table of Contents

ITEM 9B. OTHER INFORMATION

Securities Trading Plans of Directors and Executive Officers

The following officers, as defined in Rule 16a-1(f) of the Exchange Act, adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the last fiscal quarter.

On July 24, 2025 , Scott DeBoer our Executive Vice President, Chief Technology and Products Officer , adopted a Rule 10b5-1 trading arrangement providing for the sale of an aggregate of up to 82,000 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The first date that sales of any shares are permitted to be sold under the trading arrangement is October 25, 2025, and subsequent sales under the trading arrangement may occur on a regular basis for the duration of the trading arrangement. The trading arrangement will terminate no less than one year from the date the plan is entered into, or earlier if all transactions under the trading arrangement are completed.

On July 31, 2025 , Mark Murphy , our Executive Vice President and Chief Financial Officer , modified an existing Rule 10b5-1 trading arrangement that was originally entered into on April 22, 2025. The modified trading arrangement provides for the sale of up to 126,000  shares of common stock. The first date that sales of any shares are permitted to be sold under the modified trading arrangement, is October 30, 2025, and subsequent sales may occur from time to time for the duration of the trading arrangement until July 31, 2026 , or earlier if all transactions under the trading arrangement are completed. The modified trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).

No other directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the last fiscal quarter.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

PART III

Certain information concerning our executive officers is included under the caption, “Information About Our Executive Officers” in Part I, Item 1 of this report. Other information required by Items 10, 11, 12, 13, and 14 will be contained in our 2025 Proxy Statement which will be filed with the SEC within 120 days after August 28, 2025 and is incorporated herein by reference.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

ITEM 11. EXECUTIVE COMPENSATION

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

103 | 2025 10-K

Table of Contents

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULE

(a) The following documents are filed as part of this report:
1 Financial Statements: See our consolidated financial statements under Item 8.

2 Financial Statement Schedule:
See “Schedule II – Valuation and Qualifying Accounts” within Item 15 below.

Certain Financial Statement Schedules have been omitted since they are either not required, not applicable, or the information is otherwise included.

3 Exhibits. See “Index to Exhibits” within Item 15 below.

104

Table of Contents

SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
(In millions)

  Balance at
Beginning of
Year
Charged
(Credited) to
Income Tax
Provision Currency
Translation
and Charges
to Other
Accounts Balance at
End of
Year

Deferred Tax Asset Valuation Allowance        
Year ended August 28, 2025 $ 593   $ 35   $ 6   $ 634  
Year ended August 29, 2024 528   57   8   593  
Year ended August 31, 2023 471   58   ( 1 ) 528  

105 | 2025 10-K

Table of Contents

Index to Exhibits

Exhibit Number Description of Exhibit Filed Herewith Form Period Ending Exhibit/ Appendix Filing Date
3.1 Restated Certificate of Incorporation of the Registrant
8-K 99.2 1/26/15
3.2 Amended and Restated Bylaws of Registrant as of July   17 , 202 5

8-K
3.1
7/18/25
4.1 Indenture, dated as of February   6, 2019, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as Trustee
8-K 4.1 2/6/19
4.2 First Supplemental Indenture, dated as of February 6, 2019, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee
8-K 4.2 2/6/19
4.3 Form of Note for Micron Technology, Inc.’s 5.327% Senior Notes due 2029 (included in Exhibit   4.2)
8-K 4.5 2/6/19
4.4
Second Supplemental Indenture, dated as of July   12, 2019, by and between Micron Technology,   Inc. and U.S. Bank National Association, as Trustee
8-K 4.2 7/12/19
4.5 Form of Note for Micron Technology,   Inc.’s 4.663% Senior Notes due 2030 (included in Exhibit   4. 4 )
8-K 4.4 7/12/19
4.6 Fourth Supplemental Indenture, dated as of November   1, 2021, by and between Micron Technology,   Inc. and U.S. Bank National Association, as Trustee
8-K 4.2 11/1/21
4.7 Form of Note for Micron Technology,   Inc.’s 2.703% Senior Notes due 2032 (included in Exhibit   4. 6 )
8-K 4.3 11/1/21
4.8 Form of Note for Micron Technology,   Inc.’s 3.366% Senior Notes due 2041 (included in Exhibit   4. 6 )
8-K 4.4 11/1/21
4.9 Form of Note for Micron Technology,   Inc.’s 3.477% Senior Notes due 2051 (included in Exhibit   4. 6 )
8-K 4.5 11/1/21
4.10 Description of Registrant’s Securities
10-K
9/1/22 4.12
10/7/22
4.11 Fifth Supplemental Indenture, dated as of October   31, 2022, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.2
10/31/22
4.12 Form of Note for Micron Technology,   Inc.’s 6.750% Senior Notes due 2029 (included in Exhibit   4.1 1 )
8-K
4.3
10/31/22
4.13 Sixth Supplemental Indenture, dated as of February   9, 2023, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.3
2/9/23
4.14 Form of Note for Micron Technology,   Inc.’s 5.875% Senior Notes due 2033 (included in Exhibit   4.1 3 )
8-K
4.5
2/9/23
4.15 Seventh Supplemental Indenture, dated as of April   11, 2023, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.2
4/11/23
4.16 Form of Note for Micron Technology,   Inc.’s 5.375% Senior Notes due 2028 (included in Exhibit   4.1 5 )
8-K
4.3
4/11/23
4.17 Form of Note for Micron Technology,   Inc.’s 5.875% Senior Notes due 2033 (included in Exhibit   4.1 5 )
8-K
4.4
4/11/23
4.18 Eighth Supplemental Indenture, dated as of January   12, 2024, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.2
1/12/24
4.19 Form of Note for Micron Technology,   Inc.’s 5.30% Senior Notes due 2031 (incorporated by reference from Exhibit   4. 1 8 hereto)
8-K
4.3
1/12/24
4.20 N inth Supplemental Indenture, dated as of January   16, 202 5, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.2
1/16/25
4.21 F orm of Note for Micron Technology,   Inc. ’ s 5. 80% Senior N otes due 20 35 (included in Exhibit   4. 2 0 )
8-K
4.3
1/16/25

106

Table of Contents

Exhibit Number Description of Exhibit Filed Herewith Form Period Ending Exhibit/ Appendix Filing Date
4.22 Tenth Supplemental Indenture, dated as of April   29, 2025, by and between Micron Technology,   Inc. and U.S. Bank Trust Company, National Association, as Trustee
8-K
4.2
4/29/25
4.23 Form of Note for Micron Technology,   Inc.’s 5.65% Senior Notes due 2032 (included in Exhibit   4. 2 2 )
8-K
4.3
4/29/25
4.24 Form of Note for Micron Technology,   Inc.’s 6.05% Senior Notes due 2035 (included in Exhibit   4. 2 2 )
8-K
4.4
4/29/25
10.1* Micron Technology,   Inc. Executive Officer Performance Incentive Plan
DEF 14A B 12/7/17
10.2* Amended and Restated 2004 Equity Incentive Plan
10-Q
12/1/22 10.1
12/22/22
10.3* 2004 Equity Incentive Plan Forms of Agreement and Terms and Conditions
10-Q
12/1/22 10.2
12/22/22
10.4* Amended and Restated 2007 Equity Incentive Plan
DEF 14A A 12/1/20
10.5* 2007 Equity Incentive Plan Forms of Agreement and Terms and Conditions
10-Q 12/1/22 10.3
12/22/22
10.6* Nonstatutory Stock Option Plan, as a mended
10-K 9/1/16 10.10 10/28/16
10.7* Nonstatutory Stock Option Plan Form of Agreement and Terms and Conditions
10-K 9/1/16 10.11 10/28/16
10.8* Form of Indemnification Agreement between the Registrant and its officers and directors
10-Q 2/27/25 10.5
3/21/25
10.9* Form of Severance Agreement
8-K 99.2 11/1/07
10.10* Deferred Compensation Plan, as amended

10-K
8/31/23 10.10
10/6/23
10.11* Amended and Restated Executive Agreement by and between Micron Technology,   Inc. and Sanjay Mehrotra
10-K
9/1/22 10.11
10/7/22
10.12* Severance Benefits for Sumit Sadana
10-Q 11/30/17 10.70 12/20/17
10.13* Form of Amendment to Executive/Severance Agreement
8-K 99.1 11/13/17
10.14* Severance Benefits for Manish Bhatia
10-Q 11/30/17 10.74 12/20/17
10.15* Micron Technology, Inc. Employee Stock Purchase Plan, as amended and restated
10-Q 6/2/22 10.1 7/1/22
10.16* Severance Benefits for Mark Murphy
10-Q 6/2/22 10.3 7/1/22
10.17*
Form of Consent for Named Executive Officers
10-Q
3/2/23 10.5 3/29/23
10.18*
Executive Officer Cash Severance Policy
10-Q
11/30/23 10.1 12/21/23
10.19*
Severance Policy Acknowledgement Letter for Sanjay Mehrotra
10-Q
11/30/23 10.2 12/21/23
10.20*
Amended and Restated Severance Agreement by and between Micron Technology,   Inc. and Scott   J. DeBoer
10-Q
11/30/23 10.3 12/21/23
10.21 Term Loan Credit Agreement, dated as of January   17, 2025, by and among Micron Technology,   Inc., as borrower, PNC Bank, National Association, as administrative agent, the other agents party thereto, and each financial institution party from time to time thereto
10-Q
2/27/25 10.1
3/21/25
10.22*
Amended and Restated 2007 Equity Incentive Plan Forms of Agreement and Terms and Conditions
10-Q
2/27/25 10.4
3/21/25
10.23*
2025 Equity Incentive Plan
10-Q
2/27/25 10.2
3/21/25
10.24*
2025 Equity Incentive Plan Forms of Agreement and Terms and Conditions
S-8
99.2
1/21/25
10.25*
2 025 Director Compensation Plan
10-Q
2/27/25 10.6
3/21/25
10.26^
D irect Funding Agreement, dated December   9, 2024, by and between Micron Idaho Semiconductor Manuf acturing (Triton)   LLC and U.S. Department of Commerce
10-Q
2/27/25 10.7
3/21/25

107 | 2025 10-K

Table of Contents

Exhibit Number Description of Exhibit Filed Herewith Form Period Ending Exhibit/ Appendix Filing Date
10.27^
Direct Funding Agreement, dated December   9, 2024, by and between Micron New York Semiconductor Manufacturing   LLC and U.S. Department of Commerce
10-Q
2/27/25 10.8
3/21/25
10.28 Guarantee and Equity Contribution Agreement, by and between Micron Technology,   Inc. and U.S. Department of Commerce
10-Q
2/27/25 10.9
3/21/25
10.29 Credit Agreement, dated as of March   12, 2025, by and among Micron Technology,   Inc., as borrower, HSBC Bank USA, National Association, as administrative agent, the other agents party thereto, and each financial institution party from time to time thereto
10-Q
2/27/25 10.10
3/21/25
10.30^
Amendment No.   1 to Direct Funding Agreement, dated January   17 , 202 5 , by and between Micron Idaho Semiconductor Manufacturing (Triton)   LLC and U.S. Department of Commerce
10-Q
2/27/25 10.11
3/21/25
10.31^
Amendment No.   1 to Direct Funding Agreement, dated January   1 7 , 202 5 , by and between Micron New York Semiconductor Manufacturing   LLC and U.S. Department of Commerce
10-Q
2/27/25 10.12
3/21/25
10.32^
A mendment No .   2 to Direct Funding Agreement, dated Ju ne   11 , 2025, by and between Micron Idaho Semiconductor Manufacturing (Triton)   LLC and U.S. Department of Commerce
X

10.33^
Amendment No.   2 to Direct Funding Agreement, dated June   11 , 2025, by and between Micron New York Semiconductor Manufacturing   LLC and U.S. Department of Commerce
X

10.34 A mendment and Restated Guarantee and Equity Cont ribution Agreement , dated June   11, 2025, by and between Micron T echnology,   Inc. and the U. S. Department of Commerce
X

19.1 Insider Trading Policy of the Registrant
X

21.1 Subsidiaries of the Registrant
X
23.1 Consent of Independent Registered Public Accounting Firm
X
31.1 Rule 13a-14(a) Certification of Chief Executive Officer
X
31.2 Rule 13a-14(a) Certification of Chief Financial Officer
X
32.1 Certification of Chief Executive Officer Pursuant to 18   U.S.C.   1350
X
32.2 Certification of Chief Financial Officer Pursuant to 18   U.S.C.   1350
X
97.1 Compensation Recoupment (Clawback) Policy, as amended and restated

10-K
8/31/23 97.1 10/6/23
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document X
101.SCH Inline XBRL Taxonomy Extension Schema Document X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
X

* Indicates management contract or compensatory plan or arrangement.
^ Certain portions of this exhibit have been redacted because they are both not material and is the type that the Registrant treats as private or confidential. The Registrant hereby agrees to furnish supplementally to the Securities and Exchange Commission, upon its request, an unredacted copy of this exhibit.

ITEM 16. FORM 10-K SUMMARY

None.

108

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  Micron Technology, Inc.
Date October 3, 2025 By: /s/ Mark Murphy
  Mark Murphy
Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

109 | 2025 10-K

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature Title Date

/s/ Sanjay Mehrotra Chairman, President and
October 3, 2025
(Sanjay Mehrotra) Chief Executive Officer
 
(Principal Executive Officer)

/s/ Mark Murphy Executive Vice President and October 3, 2025
(Mark Murphy) Chief Financial Officer  
  (Principal Financial Officer)  

/s/ Scott Allen Corporate Vice President and October 3, 2025
(Scott Allen) Chief Accounting Officer  
  (Principal Accounting Officer)  

/s/ Richard M. Beyer Director October 3, 2025
(Richard M. Beyer)  

/s/ Lynn A. Dugle
Lead Independent Director
October 3, 2025
(Lynn A. Dugle)

/s/ Steven J. Gomo
Director October 3, 2025
(Steven J. Gomo)
   

/s/ Linnie M. Haynesworth
Director October 3, 2025
(Linnie M. Haynesworth)

/s/ T. Mark Liu
Director October 3, 2025
(T. Mark Liu)

/s/ Mary Pat McCarthy Director October 3, 2025
(Mary Pat McCarthy)    

/s/ A. Christine Simons
Director October 3, 2025
(A. Christine Simons)

/s/ Robert H. Swan
Director October 3, 2025
(Robert H. Swan)

/s/ MaryAnn Wright Director October 3, 2025
(MaryAnn Wright)    

110